Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink

September 22, 2016Posted inDrug Safety Studies, Safety of other important drugs, Select Publications
Journal: BMJ (Clinical research ed.) Authors: Katrina Wilcox Hagberg, Hozefa A Divan, Rebecca Persson, J Curtis Nickel, Susan S Jick NLM Citation: Hagberg KW, Divan HA, Persson R, Nickel JC, Jick SS. Risk of…

Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data

April 21, 2011Posted inDrug Safety Studies, Safety of hormonal contraceptives, Select Publications
Journal: BMJ Authors: Susan S Jick, Rohini K Hernandez NLM Citation: Jick SS, Hernandez RK. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using…

Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database

April 21, 2011Posted inDrug Safety Studies, Safety of hormonal contraceptives, Select Publications
Journal: BMJ Authors: Lianne Parkin, Katrina Sharples, Rohini K Hernandez, Susan S Jick NLM Citation: Parkin L, Sharples K, Hernandez RK, Jick SS. Risk of venous thromboembolism in users of oral contraceptives containing…